Norgaard v. DePuy Orthopaedics, Inc.

121 F.3d 1074, 38 Fed. R. Serv. 3d 586, 1997 U.S. App. LEXIS 20517, 1997 WL 428882
CourtCourt of Appeals for the Seventh Circuit
DecidedJuly 31, 1997
DocketNo. 96-3892
StatusPublished
Cited by26 cases

This text of 121 F.3d 1074 (Norgaard v. DePuy Orthopaedics, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Norgaard v. DePuy Orthopaedics, Inc., 121 F.3d 1074, 38 Fed. R. Serv. 3d 586, 1997 U.S. App. LEXIS 20517, 1997 WL 428882 (7th Cir. 1997).

Opinion

EASTERBROOK, Circuit Judge.

In 1987 Norma Norgaard’s physician fitted her with an artificial hip, including a socket [1075]*1075of a novel design sold as an “investigational device” under the Medical Device Amendments to the Food, Drug, and Cosmetic Act. See 21 U.S.C. § 360j(g). Seven years later her physician replaced the socket because its polyethylene liner had fractured. Norgaard and her husband then sued the manufacturer and designer of the prosthetic device under the common law of Illinois, contending that the liner’s design was defective. Defendants removed the case to federal court under the diversity jurisdiction. The court entered summary judgment in their favor on the basis of Slater v. Optical Radiation Corp., 961 F.2d 1330 (7th Cir.1992), which held that 21 U.S.C. § 360k(a)(l) — which negates application to an investigational medical device of any state “requirement” that is “different from, or in addition to, any requirement applicable under this chapter” unless the Secretary of Health and Human Services approves the state’s additional requirement — preempts the application of state tort law to claims that devices approved by the FDA for investigation in clinical trials suffer from design defects. The purpose of the investigation, we observed, is to determine whether the device is suitable for general use, and awards of damages on a defective-design theory to persons who agree to participate in the trials cognizant of the risks would disrupt the progress of medicine. Federal law entitles the producers of investigational devices to hold users to their bargains; state tort law cannot undermine contracts protected by federal law.

The district court entered its judgment on April 18, 1996. Two months later, the Supreme Court held in Medtronic, Inc. v. Lohr, — U.S. -, 116 S.Ct. 2240, 135 L.Ed.2d 700 (1996), that § 360k(a) does not preempt claims under state common law when the medical device in question has been cleared for market as “substantially equivalent” to a device already being sold. See 21 U.S.C. § 360e(b)(l)(B). Medtronic furnished the Norgaards with arguments they could have used to challenge the holding of Slater. But they had not filed a notice of appeal, or a motion in the district court under Fed. R.Civ.P. 59(e), to protect their rights in the event Medtronic should yield a favorable decision. Their lawyer was unaware that Medtronic was pending before the Supreme Court — unaware, too, of the conflict among the circuits, see — U.S. at - n. 6, 116 S.Ct. at 2250 n. 6, that led to the grant of certiorari. On July 12, 1996, sixteen days after the Court released Medtronic, and 85 days after the entry of judgment in the district court, the Norgaards filed a motion for relief from judgment under Fed.R.Civ.P. 60(b). They appeal from its denial. While their appeal was pending, our court held that Medtronic does not upset Slater. Chambers v. Osteonics Corp., 109 F.3d 1243 (7th Cir.1997). For reasons that will become apparent, we do not rely on this, lest the outcome imply that another Rule 60(b) motion would be in order should future developments call Chambers into question.

Losing parties have 30 days in which to appeal. Fed. R.App. P. 4(a)(1). This time may be extended to 60 on a showing of “good cause” (for motions filed before the expiration of the original 30 days) or “excusable neglect” (for motions filed later). If counsel had learned during this second 30 days that Medtronic was under advisement, and asked for permission to file a belated notice of appeal, the district court would have said no. Ignorance of the Supreme Court’s docket, although “neglect,” is not “excusable” — it is nothing but negligence, which does not justify untimely action. United States v. Marbley, 81 F.3d 51 (7th Cir.1996); Prizevoits v. Indiana Bell Telephone Co., 76 F.3d 132 (7th Cir.1996). Cf. Pioneer Investment Services Co. v. Brunswick Associates Limited Partnership, 507 U.S. 380, 395-97, 113 S.Ct. 1489, 1498-99, 123 L.Ed.2d 74, (1993). A prudent lawyer seeking to overcome a defense of preemption will find out how the statute is understood by other courts, a step that would have led counsel to the grant of certiorari in Medtronic. Doing this research only after judgment in the district court — indeed, after the time for appeal has expired — is inexcusable. (As it happens, the Norgaards’ lawyer learned about Medtronic not as the result of research, but from a report of the decision in the Chicago Daily Law Bulletin.) The Norgaards accordingly have not sought relief under Rule 60(b)(1), which permits the reopening of judgments on account of “mistake, [1076]*1076inadvertence, surprise, or excusable neglect”. Their motion rests entirely on Rule 60(b)(6), which covers “any other reason justifying relief from the operation of the judgment” (emphasis added).

The time limit in Rule 4(a)(1) would not be worth much if the losing side could revive the suit and proceed to the court of appeals by the expedient of filing a motion under Rule 60(b)(6). Ackermann v. United States, 340 U.S. 193, 71 S.Ct. 209, 95 L.Ed. 207 (1950), disapproved the use of Rule 60(b)(6) to have a second chance at an appeal. Ackermann and Keilbar lost in the district court. Keilbar appealed; Ackermann did not. After the court of appeals ruled in Keilbar’s favor on grounds equally applicable to Ackermann, he filed a Rule 60(b) motion. To no avail, the Court held: “[Ackermann] made a considered choice not to appeal, apparently because he did not feel that an appeal would prove to be worth what he thought was a required sacrifice of his home [to underwrite the expense].... [Aekermann] cannot be relieved of such a choice because hindsight seems to indicate to him that his decision not to appeal was probably wrong, considering the outcome of the Keilbar case. There must be an end to litigation someday, and free, calculated, deliberate choices are not to be relieved from.” 340 U.S. at 198, 71 S.Ct. at 212: If Rule 60(b) cannot be used to obtain a belated appeal from a judgment known to be wrong, given subsequent decisions of the court of appeals, it cannot be used to obtain a belated appeal from a judgment that might or might not be wrong, in light of subsequent decisions.

Today’s case could have been decided in one line, with a citation to Ackermann, but for this passage in Polites v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bastian v. Abrams Gas Inc.
E.D. Wisconsin, 2023
White v. United States
S.D. Illinois, 2020
Monika Salata v. Weyerhaeuser Company
757 F.3d 695 (Seventh Circuit, 2014)
Nash v. Hepp
740 F.3d 1075 (Seventh Circuit, 2014)
Doe-2 v. White
920 F. Supp. 2d 919 (C.D. Illinois, 2013)
O'HARA v. LaHood
756 F. Supp. 2d 75 (District of Columbia, 2010)
Coghlan v. Mineta
District of Columbia, 2010
Fox v. American Airlines, Inc.
389 F.3d 1291 (D.C. Circuit, 2004)
Allen v. LTV Steel Co.
68 F. App'x 718 (Seventh Circuit, 2003)
In Re DeLaughter
295 B.R. 317 (N.D. Indiana, 2003)
Snyder v. Barry Realty, Inc.
60 F. App'x 613 (Seventh Circuit, 2003)
Marvin D. Gleash, Sr. v. Michael Yuswak
308 F.3d 758 (Seventh Circuit, 2002)
Casio Computer Co. v. Noren
35 F. App'x 247 (Seventh Circuit, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
121 F.3d 1074, 38 Fed. R. Serv. 3d 586, 1997 U.S. App. LEXIS 20517, 1997 WL 428882, Counsel Stack Legal Research, https://law.counselstack.com/opinion/norgaard-v-depuy-orthopaedics-inc-ca7-1997.